Neogenomics Inc
NEO5.500USD
+0.340+6.59%
Horário de mercado （ET）Cotações atrasadas em 15 min
707.75MValor de mercado
PerdaP/L TTM
Mais detalhes de Neogenomics Inc Empresa
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Informações da empresa
Código da empresaNEO
Nome da EmpresaNeogenomics Inc
Data de listagemDec 10, 2012
CEOMr. Antony P. Zook
Número de funcionários2200
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 10
Endereço9490 Neogenomics Way
CidadeFORT MYERS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33912
Telefone12397680600
Sitehttps://neogenomics.com/
Código da empresaNEO
Data de listagemDec 10, 2012
CEOMr. Antony P. Zook
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
166.66K
+21.81%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
23.59K
+108.10%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
166.66K
+21.81%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
23.59K
+108.10%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
Distribuição de ações
Atualizado em: qua, 14 de mai
Atualizado em: qua, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
11.01%
First Light Asset Management, LLC
4.68%
Janus Henderson Investors
4.44%
State Street Global Advisors (US)
3.94%
Other
61.77%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
11.01%
First Light Asset Management, LLC
4.68%
Janus Henderson Investors
4.44%
State Street Global Advisors (US)
3.94%
Other
61.77%
Tipos de investidores
Investidores
Proporção
Investment Advisor
50.11%
Investment Advisor/Hedge Fund
37.15%
Hedge Fund
7.37%
Research Firm
1.52%
Individual Investor
1.19%
Pension Fund
1.13%
Bank and Trust
0.58%
Sovereign Wealth Fund
0.39%
Insurance Company
0.04%
Other
0.51%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
569
127.92M
99.03%
-12.74M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
18.29M
14.21%
-356.84K
-1.91%
Mar 31, 2025
The Vanguard Group, Inc.
14.23M
11.06%
+17.23K
+0.12%
Mar 31, 2025
First Light Asset Management, LLC
6.04M
4.7%
+2.88M
+90.77%
Mar 31, 2025
Janus Henderson Investors
5.74M
4.46%
-424.04K
-6.88%
Mar 31, 2025
State Street Global Advisors (US)
5.09M
3.95%
-109.12K
-2.10%
Mar 31, 2025
Greenhouse Funds LLLP
4.71M
3.66%
+6.43K
+0.14%
Mar 31, 2025
Macquarie Investment Management
4.68M
3.63%
+864.39K
+22.67%
Mar 31, 2025
Schroder Investment Management North America Inc.
4.31M
3.35%
+509.99K
+13.42%
Mar 31, 2025
Brown Advisory
3.87M
3.01%
-2.28M
-37.10%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.85M
2.99%
+408.27K
+11.88%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
SPDR S&P Health Care Services ETF
1.78%
Invesco S&P SmallCap Health Care ETF
0.67%
WisdomTree BioRevolution Fund
0.63%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.34%
iShares U.S. Healthcare Providers ETF
0.15%
Inspire Small/Mid Cap ESG ETF
0.15%
Federated Hermes MDT Small Cap Core ETF
0.12%
Nuveen ESG Small-Cap ETF
0.09%
iShares ESG Select Screened S&P Small-Cap ETF
0.08%
SPDR S&P 600 Small Cap Value ETF
0.08%
Ver Mais
SPDR S&P Health Care Services ETF
Proporção1.78%
Invesco S&P SmallCap Health Care ETF
Proporção0.67%
WisdomTree BioRevolution Fund
Proporção0.63%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.34%
iShares U.S. Healthcare Providers ETF
Proporção0.15%
Inspire Small/Mid Cap ESG ETF
Proporção0.15%
Federated Hermes MDT Small Cap Core ETF
Proporção0.12%
Nuveen ESG Small-Cap ETF
Proporção0.09%
iShares ESG Select Screened S&P Small-Cap ETF
Proporção0.08%
SPDR S&P 600 Small Cap Value ETF
Proporção0.08%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
